Gene · 1213
Papers3,108
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,108
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cooperativity of membrane-protein and protein-protein interactions control membrane remodeling by epsin 1 and affects clathrin-mediated endocytosis. | Cell Mol Life Sci | 2021 | 32997199 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis. | Anticancer Drugs | 2021 | 32932275 | PubTator, text mining | PubMed |
| A Tale of 2 Morphologies: Diagnostic Pitfalls in TFEB-Associated Renal Cell Carcinomas, Including a Novel NEAT1-TFEB Fusion. | Int J Surg Pathol | 2021 | 32886007 | PubTator, text mining | PubMed |
| TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. | Mol Psychiatry | 2021 | 32753686 | PubTator, text mining | PubMed |
| A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. | Genes Chromosomes Cancer | 2021 | 32749039 | PubTator, text mining | PubMed |
| POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation. | Protein Cell | 2021 | 32666500 | PubTator, text mining | PubMed |
| Peculiar protrusions along tanycyte processes face diverse neural and nonneural cell types in the hypothalamic parenchyma. | J Comp Neurol | 2021 | 32515035 | PubTator, text mining | PubMed |
| Exome sequencing identified six copy number variations as a prediction model for recurrence of primary prostate cancers with distinctive prognosis. | Transl Cancer Res | 2020 | 35117583 | PubTator, text mining | PubMed |
| A Catalog of 5' Fusion Partners in ROS1-Positive NSCLC Circa 2020. | JTO Clin Res Rep | 2020 | 34589944 | PubTator, text mining | PubMed |
| TPD52L1-ROS1 Rearrangement as a New Acquired Resistance Mechanism to Osimertinib That Responds to Crizotinib in Combination With Osimertinib in Lung Adenocarcinoma. | JTO Clin Res Rep | 2020 | 34589932 | PubTator, text mining | PubMed |
| Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure. | Nanomicro Lett | 2020 | 34138224 | PubTator, text mining | PubMed |
| Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | Front Cell Dev Biol | 2020 | 33644029 | PubTator, text mining | PubMed |
| Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis. | Front Oncol | 2020 | 33598433 | PubTator, text mining | PubMed |
| Global variability analysis of mRNA and protein concentrations across and within human tissues. | NAR Genom Bioinform | 2020 | 33575562 | PubTator, text mining | PubMed |
| Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1. | Front Cardiovasc Med | 2020 | 33553253 | PubTator, text mining | PubMed |
| Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer's disease neurons. | Brain Commun | 2020 | 33543132 | PubTator, text mining | PubMed |
| Novel Hybrid CHC from β-carboline and N-Hydroxyacrylamide Overcomes Drug-Resistant Hepatocellular Carcinoma by Promoting Apoptosis, DNA Damage, and Cell Cycle Arrest. | Front Pharmacol | 2020 | 33536926 | PubTator, text mining | PubMed |
| Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction. | Front Pharmacol | 2020 | 33510640 | PubTator, text mining | PubMed |
| The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19. | Front Pharmacol | 2020 | 33390948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/papers?page=47